| The pharmacokinetics and the pharmacodynamics of cannabinoids CJ Lucas, P Galettis, J Schneider British journal of clinical pharmacology 84 (11), 2477-2482, 2018 | 788 | 2018 |
| Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes MJ McKeage, SJ Berners-Price, P Galettis, RJ Bowen, W Brouwer, L Ding, ... Cancer chemotherapy and pharmacology 46, 343-350, 2000 | 269 | 2000 |
| Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs D Screnci, MJ McKeage, P Galettis, TW Hambley, BD Palmer, BC Baguley British journal of cancer 82 (4), 966-972, 2000 | 253 | 2000 |
| In vitro antitumour and hepatotoxicity profiles of Au (I) and Ag (I) bidentate pyridyl phosphine complexes and relationships to cellular uptake JJ Liu, P Galettis, A Farr, L Maharaj, H Samarasinha, AC McGechan, ... Journal of Inorganic Biochemistry 102 (2), 303-310, 2008 | 238 | 2008 |
| Emerging roles for phospholipase A2 enzymes in cancer KF Scott, M Sajinovic, J Hein, S Nixdorf, P Galettis, W Liauw, P de Souza, ... Biochimie 92 (6), 601-610, 2010 | 194 | 2010 |
| A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute … N Solowij, S Broyd, L Greenwood, H van Hell, D Martelozzo, K Rueb, ... European archives of psychiatry and clinical neuroscience 269 (1), 17-35, 2019 | 187 | 2019 |
| Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects LM Dryburgh, NS Bolan, CPL Grof, P Galettis, J Schneider, CJ Lucas, ... British journal of clinical pharmacology 84 (11), 2468-2476, 2018 | 169 | 2018 |
| Structural and solution chemistry of gold (I) and silver (I) complexes of bidentate pyridyl phosphines: selective antitumour agents SJ Berners-Price, RJ Bowen, P Galettis, PC Healy, MJ McKeage Coordination Chemistry Reviews 185, 823-836, 1999 | 155 | 1999 |
| Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular cannabis users: a pragmatic open-label clinical trial N Solowij, SJ Broyd, C Beale, JA Prick, L Greenwood, H Van Hell, C Suo, ... Cannabis and cannabinoid research 3 (1), 21-34, 2018 | 151 | 2018 |
| Prolonged cannabidiol treatment effects on hippocampal subfield volumes in current cannabis users C Beale, SJ Broyd, Y Chye, C Suo, M Schira, P Galettis, JH Martin, ... Cannabis and cannabinoid research 3 (1), 94-107, 2018 | 89 | 2018 |
| Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer MH Pourgholami, M Szwajcer, M Chin, W Liauw, J Seef, P Galettis, ... Cancer chemotherapy and pharmacology 65, 597-605, 2010 | 75 | 2010 |
| Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction? JH Martin, J Schneider, CJ Lucas, P Galettis Clinical pharmacokinetics 57, 539-545, 2018 | 57 | 2018 |
| Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice A Ehteda, P Galettis, K Pillai, DL Morris BMC cancer 13, 1-13, 2013 | 49 | 2013 |
| Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin D Screnci, HM Er, TW Hambley, P Galettis, W Brouwer, MJ McKeage British journal of cancer 76 (4), 502-510, 1997 | 48 | 1997 |
| Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia P Galettis, J Boutagy, DDF Ma British journal of cancer 70 (2), 324-329, 1994 | 43 | 1994 |
| Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology BD Menz, SL Stocker, N Verougstraete, D Kocic, P Galettis, CP Stove, ... British Journal of Clinical Pharmacology 87 (2), 227-236, 2021 | 40 | 2021 |
| Quantitative determination of platinum complexes in human plasma generated from the oral antitumour drug JM216 using directly coupled high-performance liquid chromatography … P Galettis, JL Carr, JW Paxton, MJ McKeage Journal of Analytical Atomic Spectrometry 14 (6), 953-956, 1999 | 35 | 1999 |
| A validated method for the detection of 32 bath salts in oral fluid M Williams, J Martin, P Galettis Journal of Analytical Toxicology 41 (8), 659-669, 2017 | 34 | 2017 |
| Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice A Ehteda, P Galettis, SWL Chu, K Pillai, DL Morris Anticancer research 32 (9), 3659-3666, 2012 | 34 | 2012 |
| Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate X Jiang, P Galettis, M Links, PL Mitchell, AJ McLachlan British journal of clinical pharmacology 65 (3), 326-333, 2008 | 34 | 2008 |
